EFM
E Fund Management Portfolio holdings
AUM
$2.1B
1-Year Return
23.31%
This Quarter Return
-7.88%
1 Year Return
+23.31%
3 Year Return
+155.42%
5 Year Return
–
10 Year Return
–
AUM
$1.07B
AUM Growth
-$29.7M
(-2.7%)
Cap. Flow
+$88.7M
Cap. Flow
% of AUM
8.26%
Top 10 Holdings %
Top 10 Hldgs %
55.73%
Holding
349
New
26
Increased
163
Reduced
134
Closed
15
Top Buys
| 1 |
TSMC
TSM
|
$29.5M |
| 2 |
Grab
GRAB
|
$28.9M |
| 3 |
Qualcomm
QCOM
|
$21.2M |
| 4 |
Advanced Micro Devices
AMD
|
$16.3M |
| 5 |
Sea Limited
SE
|
$14.7M |
Top Sells
| 1 |
Mercado Libre
MELI
|
$25.6M |
| 2 |
Meta Platforms (Facebook)
META
|
$13.4M |
| 3 |
DIDI
DiDi Global Inc. American depositary shares, each four representing one Class A ordinary share
DIDI
|
$6.5M |
| 4 |
IMAB
I-MAB
IMAB
|
$1.24M |
| 5 |
ProShares Ultra Gold
UGL
|
$1.01M |
Sector Composition
| 1 | Consumer Discretionary | 34.29% |
| 2 | Technology | 26.19% |
| 3 | Communication Services | 11.91% |
| 4 | Healthcare | 11.24% |
| 5 | Real Estate | 7.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
176
Arcus Biosciences
RCUS
$1.3B
| $411K | 0.04% |
15,720
-2,055
| -12% | -$53.7K |
|
|
IMAB
177
I-MAB
IMAB
$358M
| $410K | 0.04% |
102,157
-310,000
| -75% | -$1.24M |
|
178
Vir Biotechnology
VIR
$732M
| $410K | 0.04% |
21,284
+2,345
| +12% | +$45.2K |
|
179
Arrowhead Research
ARWR
$4.02B
| $408K | 0.04% |
12,351
-1,996
| -14% | -$65.9K |
|
180
Iovance Biotherapeutics
IOVA
$901M
| $407K | 0.04% |
42,531
-10,224
| -19% | -$97.8K |
|
181
Airbnb
ABNB
$75.8B
| $402K | 0.04% |
3,831
+181
| +5% | +$19K |
|
182
Amphenol
APH
$135B
| $402K | 0.04% |
12,018
-562
| -4% | -$18.8K |
|
183
Celldex Therapeutics
CLDX
$1.52B
| $401K | 0.04% |
14,278
+78
| +0.5% | +$2.19K |
|
184
Ultragenyx Pharmaceutical
RARE
$3.07B
| $401K | 0.04% |
9,673
+894
| +10% | +$37.1K |
|
185
Beam Therapeutics
BEAM
$2.11B
| $395K | 0.04% |
8,283
-4,954
| -37% | -$236K |
|
186
Natera
NTRA
$23.1B
| $394K | 0.04% |
9,002
-3,801
| -30% | -$166K |
|
187
Veracyte
VCYT
$2.55B
| $394K | 0.04% |
23,762
+946
| +4% | +$15.7K |
|
|
MRTX
188
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $393K | 0.04% |
5,620
-1,793
| -24% | -$125K |
|
189
Electronic Arts
EA
$42.2B
| $389K | 0.04% |
3,363
+132
| +4% | +$15.3K |
|
|
RXDX
190
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
| $385K | 0.04% |
+6,532
| New | +$385K |
|
191
Roper Technologies
ROP
$55.8B
| $383K | 0.04% |
1,066
-49
| -4% | -$17.6K |
|
192
Exact Sciences
EXAS
$10.2B
| $381K | 0.04% |
11,718
+1,098
| +10% | +$35.7K |
|
193
Twist Bioscience
TWST
$1.55B
| $381K | 0.04% |
10,817
-5,534
| -34% | -$195K |
|
194
Fate Therapeutics
FATE
$116M
| $380K | 0.04% |
16,952
-5,151
| -23% | -$115K |
|
|
ANSS
195
DELISTED
Ansys
ANSS
| $378K | 0.04% |
1,703
-41
| -2% | -$9.1K |
|
196
Enphase Energy
ENPH
$5.18B
| $377K | 0.04% |
1,359
-63
| -4% | -$17.5K |
|
197
Motorola Solutions
MSI
$79.8B
| $377K | 0.04% |
1,682
-78
| -4% | -$17.5K |
|
198
CVS Health
CVS
$93.6B
| $375K | 0.03% |
3,934
+270
| +7% | +$25.7K |
|
199
Walmart
WMT
$801B
| $374K | 0.03% |
8,658
+294
| +4% | +$12.7K |
|
200
Editas Medicine
EDIT
$248M
| $368K | 0.03% |
30,092
-9,249
| -24% | -$113K |
|